Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
J Clin Endocrinol Metab. 2020 Jan 1;105(1):266-75. doi: 10.1210/clinem/dgz046.
The gastrointestinal hormone ghrelin stimulates growth hormone secretion and appetite, but recent studies indicate that ghrelin also stimulates the secretion of the appetite-inhibiting and insulinotropic hormone glucagon-like peptide-1 (GLP-1).
To investigate the putative effect of ghrelin on GLP-1 secretion in vivo and in vitro.
A randomized placebo-controlled crossover study was performed in eight hypopituitary subjects. Ghrelin or saline was infused intravenously (1 pmol/min × kg) after collection of baseline sample (0 min), and blood was subsequently collected at time 30, 60, 90, and 120 minutes. Mouse small intestine was perfused (n = 6) and GLP-1 output from perfused mouse small intestine was investigated in response to vascular ghrelin administration in the presence and absence of a simultaneous luminal glucose stimulus. Ghrelin receptor expression was quantified in human (n = 11) and mouse L-cells (n = 3) by RNA sequencing and RT-qPCR, respectively.
Ghrelin did not affect GLP-1 secretion in humans (area under the curve [AUC; 0-120 min]: ghrelin infusion = 1.37 ± 0.05 min × nmol vs. saline infusion = 1.40 ± 0.06 min × nmol [P = 0.63]), but induced peripheral insulin resistance. Likewise, ghrelin did not stimulate GLP-1 secretion from the perfused mouse small intestine model (mean outputs during baseline/ghrelin infusion = 19.3 ± 1.6/25.5 ± 2.0 fmol/min, n = 6, P = 0.16), whereas glucose-dependent insulinotropic polypeptide administration, used as a positive control, doubled GLP-1 secretion (P < 0.001). Intraluminal glucose increased GLP-1 secretion by 4-fold (P < 0.001), which was not potentiated by ghrelin. Finally, gene expression of the ghrelin receptor was undetectable in mouse L-cells and marginal in human L-cells.
Ghrelin does not interact directly with the L-cell and does not directly affect GLP-1 secretion.
胃肠激素 ghrelin 可刺激生长激素的分泌和食欲,但最近的研究表明,ghrelin 还可刺激食欲抑制和胰岛素促分泌素胰高血糖素样肽-1(GLP-1)的分泌。
研究 ghrelin 对体内和体外 GLP-1 分泌的可能作用。
对 8 例垂体功能减退患者进行了一项随机安慰剂对照交叉研究。在采集基线样本(0 分钟)后,静脉内输注 ghrelin 或生理盐水(1 pmol/min × kg),随后在 30、60、90 和 120 分钟采血。对灌注的小鼠小肠(n = 6)进行灌注,并在存在和不存在同时腔内葡萄糖刺激的情况下,研究血管内 ghrelin 给药对 GLP-1 输出的影响。通过 RNA 测序和 RT-qPCR 分别对人(n = 11)和小鼠 L 细胞(n = 3)中的 ghrelin 受体表达进行定量。
ghrelin 并未影响人类的 GLP-1 分泌(0-120 分钟的曲线下面积 [AUC]:ghrelin 输注=1.37 ± 0.05 min × nmol vs. 生理盐水输注=1.40 ± 0.06 min × nmol [P = 0.63]),但诱导外周胰岛素抵抗。同样,ghrelin 也未刺激灌注的小鼠小肠模型中的 GLP-1 分泌(在基线/ghrelin 输注期间的平均输出为 19.3 ± 1.6/25.5 ± 2.0 fmol/min,n = 6,P = 0.16),而作为阳性对照的葡萄糖依赖性胰岛素促分泌肽给药使 GLP-1 分泌增加了一倍(P < 0.001)。腔内葡萄糖使 GLP-1 分泌增加了 4 倍(P < 0.001),而 ghrelin 并未增强这种作用。最后,ghrelin 受体的基因表达在小鼠 L 细胞中无法检测到,在人 L 细胞中仅呈边缘状态。
ghrelin 与 L 细胞不直接相互作用,也不直接影响 GLP-1 分泌。